What is tzanck test

Overview

The Tzanck test, also known as a Tzanck smear, is a diagnostic procedure used in dermatology and clinical medicine to rapidly identify certain viral infections. The test was developed in 1947 by French dermatologist Arnault Tzanck and remains a valuable screening tool in medical practice today, particularly in emergency departments and outpatient clinics.

What Infections It Detects

The Tzanck test is primarily used to diagnose two types of viral infections: herpes simplex virus (HSV) and varicella-zoster virus (VZV), which causes chickenpox and shingles. These viruses produce distinctive cellular changes that can be identified under microscopic examination. While the test can indicate the presence of these viruses, it cannot definitively distinguish between HSV-1 and HSV-2, nor can it always differentiate between HSV and VZV.

The Procedure

During a Tzanck test, a healthcare provider gently scrapes cells from the base of an active blister or lesion using a small spatula or swab. These collected cells are then placed on a glass slide and stained with special dyes, typically Giemsa stain or methylene blue. Under a microscope at high magnification, the examiner looks for characteristic cellular changes including multinucleated giant cells and nuclear molding—distinctive patterns that indicate viral infection.

Advantages of the Test

One major advantage of the Tzanck test is its speed. Results can be obtained within hours, making it much faster than traditional viral culture methods which may take days or weeks. The test requires only basic equipment and can be performed in most clinical settings, including physician offices, clinics, and emergency departments. It is also relatively inexpensive compared to other diagnostic methods, making it accessible and cost-effective for initial screening.

Limitations and Modern Alternatives

Despite its usefulness, the Tzanck test has important limitations. It cannot definitively distinguish between HSV-1 and HSV-2, nor can it always differentiate between HSV and VZV in all cases. Its sensitivity is lower than polymerase chain reaction (PCR) testing, meaning it may miss some infections. Modern medicine increasingly uses PCR testing for more accurate diagnosis, though the Tzanck test remains valuable for rapid preliminary assessment and in resource-limited settings.